two step approach first staining with ifitm1 (Cell Signaling Technology Inc)
Structured Review

Two Step Approach First Staining With Ifitm1, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/two step approach first staining with ifitm1/product/Cell Signaling Technology Inc
Average 86 stars, based on 1 article reviews
Images
1) Product Images from "Interferon Beta Drives Therapy Resistance in a Patient-Derived Model of High-Grade Serous Ovarian Cancer"
Article Title: Interferon Beta Drives Therapy Resistance in a Patient-Derived Model of High-Grade Serous Ovarian Cancer
Journal: bioRxiv
doi: 10.64898/2026.01.27.699126
Figure Legend Snippet: A. RT-qPCR analysis of IFN-1 RNA levels. B . Secreted IFN-1 protein levels detected in culture supernatant via HEK-Blue SEAP reporter assay. C . RT-qPCR analysis of IRDS genes. Dots indicate genes known to be transcribed by u-ISGF3. D . Intracellular flow cytometry of IFITM1, total STAT1, and pSTAT1(y701). One representative replicate shown. Results are displayed as n=3, unless otherwise noted, and presented as the means ± SD. Statistical significance was determined using the unpaired t-test. p-values: p ≤ 0.05 (*).
Techniques Used: Quantitative RT-PCR, Reporter Assay, Flow Cytometry
Figure Legend Snippet: A. The IC50 of SE and CR cells was significantly higher following IFNβ treatment. B . Morphology change was determined by measuring the aspect ratio (width/legth) of 60 cells from each sample (20 cells per photo, 2 photos per well, 3 wells). Scale bar = 50µm. C . BrdU staining revealed cell cycle arrest in G0-G1 following IFNβ treatment, as measured by flow cytometry. Data represent one representative replicate. D . Proliferation was detected by counting individual wells of parental and IFNβ treated cells over time. E . RT-qPCR was used to analyze STAT1, IFITM1, and PLSCR1 following 6 passages and 12 weeks following consistent low-level IFNβ treatment. F . Intracellular flow cytometry was used to measure STAT1 and pSTAT1 protein levels following chronic IFNβ treatment. One representative replicate shown. Results are displayed as n=3, unless otherwise noted, and presented as the means ± SD. Statistical significance was determined using the unpaired t-test. p-values: p ≤ 0.05 (*) and p ≤ 0.01 (**).
Techniques Used: BrdU Staining, Flow Cytometry, Quantitative RT-PCR